Aldosteronoma Clinical Features
Aldosteronoma is associated with hypertension, hypokalemia, high aldosterone and low renin levels (option d). 1, 2, 3
Pathophysiology of Aldosteronoma
- Aldosteronoma (aldosterone-producing adenoma) is characterized by excessive and autonomous production of aldosterone by the adrenal glands, independent of the renin-angiotensin system 1
- This excessive aldosterone production leads to:
- Approximately 50% of patients with primary aldosteronism have unilateral increased aldosterone production, usually due to an aldosterone-producing adenoma 1
Key Clinical Features
- Hypertension: Patients with aldosteronoma typically present with moderate to marked hypertension that is often resistant to treatment 4, 3
- Hypokalemia: A classic finding in aldosteronoma, though it may be absent in up to 50% of cases, especially in early stages 4, 1, 5
- High aldosterone levels: Elevated plasma and/or urinary aldosterone is a hallmark of aldosteronoma 1, 5
- Low renin levels: Plasma renin activity is suppressed due to the autonomous production of aldosterone 1, 2, 3
Diagnostic Approach
- The aldosterone-to-renin ratio (ARR) is the most accurate and reliable screening test for aldosteronoma 4, 2
- A positive ARR is defined as:
- Confirmatory testing is required after a positive screening test to demonstrate autonomous aldosterone production 2
- Adrenal imaging (CT or MRI) and adrenal venous sampling help differentiate between unilateral adenoma and bilateral hyperplasia 4, 2
Clinical Impact and Complications
- Aldosteronoma causes greater target organ damage than primary hypertension, including: 4, 3
- 3.7-fold increase in heart failure
- 4.2-fold increase in stroke
- 6.5-fold increase in myocardial infarction
- 12.1-fold increase in atrial fibrillation
- Increased left ventricular hypertrophy and diastolic dysfunction 4
- Increased stiffness of large arteries and widespread tissue fibrosis 4
- Increased remodeling of resistance vessels and kidney damage 4
Common Pitfalls in Diagnosis
- Relying solely on hypokalemia as a marker, as it is absent in many cases 2, 5
- Not screening high-risk patients with resistant hypertension 2
- Failing to consider medication effects on the aldosterone-renin ratio 2
- Proceeding with adrenalectomy based on imaging alone without adrenal venous sampling 4, 2
Treatment
- Unilateral laparoscopic adrenalectomy is the treatment of choice for aldosteronoma 1, 2
- Surgery improves blood pressure in nearly 100% of patients and achieves complete cure of hypertension in approximately 50% of cases 1, 2
- Medical therapy with mineralocorticoid receptor antagonists (spironolactone or eplerenone) is an alternative when surgery is not possible 1, 2